JP2004524292A5 - - Google Patents

Download PDF

Info

Publication number
JP2004524292A5
JP2004524292A5 JP2002556156A JP2002556156A JP2004524292A5 JP 2004524292 A5 JP2004524292 A5 JP 2004524292A5 JP 2002556156 A JP2002556156 A JP 2002556156A JP 2002556156 A JP2002556156 A JP 2002556156A JP 2004524292 A5 JP2004524292 A5 JP 2004524292A5
Authority
JP
Japan
Prior art keywords
compound
formula
pharmaceutically acceptable
pharmaceutical formulation
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002556156A
Other languages
English (en)
Japanese (ja)
Other versions
JP4064237B2 (ja
JP2004524292A (ja
Filing date
Publication date
Priority claimed from EP01500263A external-priority patent/EP1310480A1/en
Application filed filed Critical
Priority claimed from PCT/US2001/045866 external-priority patent/WO2002055481A1/en
Publication of JP2004524292A publication Critical patent/JP2004524292A/ja
Publication of JP2004524292A5 publication Critical patent/JP2004524292A5/ja
Application granted granted Critical
Publication of JP4064237B2 publication Critical patent/JP4064237B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002556156A 2001-01-11 2001-12-21 興奮性アミノ酸のプロドラッグ Expired - Fee Related JP4064237B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP01500007 2001-01-11
EP01500206 2001-08-02
US32978601P 2001-10-16 2001-10-16
EP01500263A EP1310480A1 (en) 2001-11-07 2001-11-07 Prodrugs of excitatory amino acids
PCT/US2001/045866 WO2002055481A1 (en) 2001-01-11 2001-12-21 Prodrugs of excitatory amino acids

Publications (3)

Publication Number Publication Date
JP2004524292A JP2004524292A (ja) 2004-08-12
JP2004524292A5 true JP2004524292A5 (cg-RX-API-DMAC7.html) 2006-08-17
JP4064237B2 JP4064237B2 (ja) 2008-03-19

Family

ID=27440162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002556156A Expired - Fee Related JP4064237B2 (ja) 2001-01-11 2001-12-21 興奮性アミノ酸のプロドラッグ

Country Status (24)

Country Link
US (1) US7256217B2 (cg-RX-API-DMAC7.html)
EP (1) EP1368304B1 (cg-RX-API-DMAC7.html)
JP (1) JP4064237B2 (cg-RX-API-DMAC7.html)
KR (1) KR20030090622A (cg-RX-API-DMAC7.html)
CN (1) CN1267407C (cg-RX-API-DMAC7.html)
AR (1) AR036007A1 (cg-RX-API-DMAC7.html)
AT (1) ATE356111T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002228737B2 (cg-RX-API-DMAC7.html)
BR (1) BR0116770A (cg-RX-API-DMAC7.html)
CA (1) CA2433667C (cg-RX-API-DMAC7.html)
CZ (1) CZ303490B6 (cg-RX-API-DMAC7.html)
DE (1) DE60127182T2 (cg-RX-API-DMAC7.html)
DZ (1) DZ3461A1 (cg-RX-API-DMAC7.html)
ES (1) ES2282315T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0400620A3 (cg-RX-API-DMAC7.html)
IL (1) IL156364A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03006186A (cg-RX-API-DMAC7.html)
NO (1) NO20033166L (cg-RX-API-DMAC7.html)
NZ (1) NZ526050A (cg-RX-API-DMAC7.html)
PE (1) PE20020829A1 (cg-RX-API-DMAC7.html)
PL (1) PL208413B1 (cg-RX-API-DMAC7.html)
SK (1) SK287934B6 (cg-RX-API-DMAC7.html)
SV (1) SV2003000836A (cg-RX-API-DMAC7.html)
WO (1) WO2002055481A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20041179B1 (hr) * 2002-06-11 2012-11-30 Eli Lilly And Company Prekursorski oblici lijekova za aminokiseline s pobuđivačkom aktivnosti
WO2010111080A2 (en) 2009-03-27 2010-09-30 Eli Lilly And Company Optimized treatment of schizophrenia
JO2978B1 (en) * 2009-12-21 2016-03-15 ايلي ليلي اند كومباني MGLU2 aids
KR101598679B1 (ko) 2011-06-17 2016-02-29 일라이 릴리 앤드 캄파니 mGlu2 수용체 효능제로서의 비시클로(3.1.0)헥산-2,6-디카르복실산 유도체
AR089718A1 (es) 2012-02-01 2014-09-10 Lilly Co Eli AGONISTAS DE mGlu2/3
WO2019201842A1 (de) 2018-04-17 2019-10-24 Bayer Aktiengesellschaft Verfahren zur herstellung von estern n-acylierter aminosäuren mit säurelabilen keto-schutzgruppenfunktionen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE206915T1 (de) 1994-08-12 2001-11-15 Lilly Co Eli Behandlung von angstzuständen
US5750566A (en) * 1994-08-12 1998-05-12 Eli Lilly And Company Synthetic excitatory amino acids
PL182285B1 (pl) 1994-08-12 2001-12-31 Lilly Co Eli Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL
IL118727A (en) 1995-06-29 2003-01-12 Lilly Co Eli (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid
ZA983930B (en) * 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
CN1182105C (zh) 1998-01-28 2004-12-29 大正制药株式会社 含氟氨基酸衍生物
GB9815542D0 (en) 1998-07-17 1998-09-16 Lilly Co Eli Bicyclohexane derivatives
US6528499B1 (en) 2000-04-27 2003-03-04 Georgetown University Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
WO2002055485A1 (en) 2001-01-11 2002-07-18 Eli Lilly And Company Prodrugs of excitatory amino acids
EP1423411A2 (en) 2001-07-09 2004-06-02 Eli Lilly And Company Prodrugs of excitatory amino acids
AU2002353845A1 (en) 2001-11-23 2003-06-10 Eli Lilly And Company Prodrugs of excitatory amino acids
AU2002361611A1 (en) 2001-12-21 2003-07-24 Eli Lilly And Company Prodrugs of excitatory amino acids

Similar Documents

Publication Publication Date Title
TW505623B (en) Excitatory amino acid receptor modulators
CN104136416B (zh) 苯基烷基氨基甲酸酯衍生物化合物以及包含该苯基烷基氨基甲酸酯衍生物化合物的药物组合物
JP2006503807A5 (cg-RX-API-DMAC7.html)
JP7036792B2 (ja) スピロ-ラクタムnmda受容体修飾因子およびその使用
EP1052246A4 (en) FLUORINE AMINO ACID DERIVATIVES
HK1052506A1 (zh) 化合物
CA2438991A1 (en) Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
US9464066B2 (en) Deuterated compounds useful for treating neurodegenerative diseases
EP1256576A1 (en) Fused imidazolium derivatives
EA016687B8 (ru) Производные циклопропиламида
US20230416219A1 (en) R-mdma crystal forms
MXPA05000435A (es) Derivados de azabiciclo como antagonistas de receptor muscarinico.
JP2002511835A (ja) 神経障害および神経病の治療に有用な受容体作動性カルシウムチャネル上の新規部位で活性な化合物
AU2001281861B2 (en) 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinicreceptor antagonists
JP2024540030A (ja) 修飾インドール化合物
US6448282B1 (en) 1H-4(5)-substituted imidazole derivatives
KR20050065646A (ko) 칼슘 채널 알파-2-델타 서브유닛에 대한 친화성을 갖는프롤린 유도체
JP2009502941A (ja) ニューロパシーおよび関連障害の治療のための方法および組成物
CA2433667A1 (en) Prodrugs of excitatory amino acids
US6500866B1 (en) 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
JP6936257B2 (ja) Eaat3阻害剤としてのピラゾール化合物
TH58080A (th) โพรดรักส์ของกรดแอมิโนเร่งเร้า
CN112225673B (zh) 氨基康普立停衍生物及其应用
CN103570669B (zh) 脑靶向o-去甲基文拉法辛酚酯类前药及制备方法和用途
US20080312253A1 (en) Pharmaceutical compositions containing pyrazole derivatives for treating as serotonin antagonist